Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

During the Trading Day
73.74 -0.45 / -0.61%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
73.75 +0.0147 / +0.02%
 
Volume: 50.2K
LLY Regular Dividend: LLY will begin trading ex-dividend on 02/10/16 with a $0.51 dividend payable to shareholders of record as of 02/12/16.

Today’s Trading

Previous close74.19
Today’s open73.43
Day’s range72.72 - 74.96
Volume5,043,535
Average volume (3 months)5,268,367
Market cap$82.2B
Dividend yield2.77%
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+3.39%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.75%
P/E ratio33.4
Price/Sales4.50
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.59+1.12%
CELGCelgene+1.32+1.33%
AZNAstraZeneca-0.10-0.35%
NVONovo Nordisk-0.44-0.94%
Data as of 4:02pm ET, 02/09/2016

Financials

Next reporting dateApril 26, 2016
EPS forecast (this quarter)$0.84
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
John C. Lechleiter
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts

Partner Offers